Iris Lavon

Summary

Country: Israel

Publications

  1. ncbi Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase
    Iris Lavon
    Leslie and Michael Gaffin Center for Neuro Oncology, Department of Neurology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Cancer Res 67:8952-9. 2007
  2. ncbi Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression
    Netta Levin
    Leslie and Michael Gaffin Center for Neuro Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel imbar
    Cancer 106:1759-65. 2006
  3. ncbi Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas
    Iris Lavon
    Leslie and Michael Gaffin Center for Neuro Oncology, Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Clin Cancer Res 13:1429-37. 2007
  4. ncbi A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation
    Iris Lavon
    Pharmos Ltd, Kiryat Weizmann, Bld 13b, Rehovot 76326, Israel
    Mol Pharmacol 64:1334-41. 2003
  5. ncbi Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors
    Eran Nizri
    Laboratory of Neuroimmunology, Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, P.O. Box 12000, Jerusalem 91120, Israel
    Neuropharmacology 50:540-7. 2006

Collaborators

  • Felix Bokstein
  • Netta Levin
  • Eran Nizri
  • Bracha Zelikovitsh
  • Yasmine Hamra-Amitay
  • Talma Brenner
  • Dana Fuchs
  • Tali Siegal
  • Yakov Fellig
  • Camille Sicsic

Detail Information

Publications5

  1. ncbi Novel mechanism whereby nuclear factor kappaB mediates DNA damage repair through regulation of O(6)-methylguanine-DNA-methyltransferase
    Iris Lavon
    Leslie and Michael Gaffin Center for Neuro Oncology, Department of Neurology, Hadassah Hebrew University Medical Center, Jerusalem, Israel
    Cancer Res 67:8952-9. 2007
    ..The findings of our study strongly suggest that NF-kappaB plays a major role in MGMT regulation and that MGMT is most probably the major player in NF-kappaB-mediated chemoresistance to alkylating agents...
  2. ncbi Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression
    Netta Levin
    Leslie and Michael Gaffin Center for Neuro Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel imbar
    Cancer 106:1759-65. 2006
    ..However, to the authors' knowledge, limited data are available regarding the 1p/19q profile and its correlation with MGMT protein expression and response to treatment with DNA-alkylating drugs...
  3. ncbi Longitudinal assessment of genetic and epigenetic markers in oligodendrogliomas
    Iris Lavon
    Leslie and Michael Gaffin Center for Neuro Oncology, Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Jerusalem, Israel
    Clin Cancer Res 13:1429-37. 2007
    ..Because little is known about the evolution of genetic and epigenetic changes that occur during tumor progression in oligodendrogliomas, we evaluated these changes in paired early and progressive oligodendrogliomas...
  4. ncbi A novel synthetic cannabinoid derivative inhibits inflammatory liver damage via negative cytokine regulation
    Iris Lavon
    Pharmos Ltd, Kiryat Weizmann, Bld 13b, Rehovot 76326, Israel
    Mol Pharmacol 64:1334-41. 2003
    ..These findings suggest that this cannabinoid derivative is an immunomodulator that could be developed as a potential drug for hepatitis as well as for other short- or long-term inflammatory diseases...
  5. ncbi Anti-inflammatory properties of cholinergic up-regulation: A new role for acetylcholinesterase inhibitors
    Eran Nizri
    Laboratory of Neuroimmunology, Department of Neurology, The Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, P.O. Box 12000, Jerusalem 91120, Israel
    Neuropharmacology 50:540-7. 2006
    ..They also emphasize the importance of cholinergic balance in neurological disorders, such as Alzheimer's disease and myasthenia gravis, in which these drugs are used...